Stephen Galli
Director/Board Member chez ATOSSA THERAPEUTICS, INC.
Fortune : 178 $ au 31/03/2024
Profil
Stephen J.
Galli is an Independent Director at Atossa Therapeutics, Inc., a Professor at Stanford University School of Medicine, and the President of the Association of Pathology Chairs.
He was formerly the President of the Collegium Internationale Allergologicum and the American Society for Investigative Pathology.
Galli received his doctorate from Harvard Medical School in 1973 and his undergraduate degree from Harvard College in 1968.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
15/03/2024 | 99 ( 0,00% ) | 178 $ | 31/03/2024 |
Postes actifs de Stephen Galli
Sociétés | Poste | Début |
---|---|---|
ATOSSA THERAPEUTICS, INC. | Director/Board Member | 01/07/2011 |
Stanford University School of Medicine | Corporate Officer/Principal | 01/02/1999 |
Association of Pathology Chairs | President | - |
Anciens postes connus de Stephen Galli
Sociétés | Poste | Fin |
---|---|---|
Collegium Internationale Allergologicum | President | - |
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | President | - |
Formation de Stephen Galli
Harvard Medical School | Doctorate Degree |
Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ATOSSA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Collegium Internationale Allergologicum | |
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | Health Technology |
Association of Pathology Chairs |